Nephrodite, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersAtlanta, GA
US patents4
SAM.gov UEIZ6U2W1BJNMH3
CAGE code8K8L7
Incorporated inDE
Brands
This company sells these brands.
- eligible patients
- end-stage kidney disease
- implantable dialysis platform
- One-time surgical implant
- Discreet lower abdominal catheter
- Cartridge-based membrane system
- proprietary membrane platform
- edge computing technology
- continuous dialysis system
- portable hemofiltration system
- liver and metabolic toxin management
- critical care including military settings
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2018–2024, 2 of them in the five years to SEP 2025.
Medical technology 4
- Implantable dialysis deviceUS 12,168,088 · granted DEC 17, 2024
- Implantable dialysis deviceUS 10,874,786 · granted DEC 29, 2020
- Portable dialysis deviceUS 10,744,250 · granted AUG 18, 2020
- Portable dialysis deviceUS 10,143,790 · granted DEC 4, 2018
Granted to Nephrodite LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Nephrodite, INC. | Atlanta | GA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.